Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Income from Continuing Operations (2016 - 2025)

Anaptysbio (ANAB) has disclosed Income from Continuing Operations for 10 consecutive years, with 49614000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations rose 327.75% year-over-year to 49614000.0, compared with a TTM value of 13232000.0 through Dec 2025, up 90.89%, and an annual FY2025 reading of 13232000.0, up 90.89% over the prior year.
  • Income from Continuing Operations was 49614000.0 for Q4 2025 at Anaptysbio, up from 15113000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 49614000.0 in Q4 2025 and bottomed at 46660000.0 in Q2 2024.
  • Average Income from Continuing Operations over 5 years is 23866550.0, with a median of 31248000.0 recorded in 2021.
  • The sharpest move saw Income from Continuing Operations crashed 6121.91% in 2022, then surged 327.75% in 2025.
  • Year by year, Income from Continuing Operations stood at 31089000.0 in 2021, then rose by 28.8% to 22134000.0 in 2022, then crashed by 90.51% to 42168000.0 in 2023, then soared by 48.34% to 21784000.0 in 2024, then soared by 327.75% to 49614000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for ANAB at 49614000.0 in Q4 2025, 15113000.0 in Q3 2025, and 38630000.0 in Q2 2025.